RNS Number : 4155Y
Marston's PLC
30 July 2024
 

30 July 2024

 

Marston's PLC (the "Company") - Notification of Transactions of Directors/Persons Discharging Managerial Responsibility

 

This notification is made in accordance with the Market Abuse Regulation.

 

Exercise of option under the Company's Deferred Bonus Plan ("DBP")

 

On 29 July 2024, the following Director exercised an option over ordinary shares in the Company under the DBP, which was granted on 25 May 2021:

 

Director

Aggregate number of shares in respect of which DBP exercised

 

Hayleigh Lupino

30,129

 

Enquiries: Bethan Raybould, General Counsel and Company Secretary, Marston's PLC, +44 (0) 1902 907250

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 Hayleigh Lupino

 

2

 

Reason for the notification

a)

 

Position/status

Director and PDMR (Chief Financial Officer)

 

b)

 

Initial notification /Amendment

Initial notification

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

Marston's PLC

 

b)

 

LEI

LEI no. 213800Q6RP3ZJ2CZR962

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 7.375p each

 

Identification code

ISIN GB00B1JQDM80

 

b)

 

Nature of the transaction

Exercise of award under the Deferred Bonus Plan

 

c)

 

Price(s) and volume(s)





 



Price(s)

Volume(s)


 



N/A

30,129


 






 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

n/a single transaction

 

n/a single transaction

 

e)

 

Date of the transaction

2024-07-29

 

f)

 

Place of the transaction

Outside a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEXEDFXLEFA